mayzent
novartis europharm limited - siponimod acid fumaric - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare selective - mayzent este indicat pentru tratamentul pacienților adulți cu scleroză multiplă secundar progresivă (spms), cu boală activă demonstrat de recidive sau caracteristici imagistice de activitate antiinflamatoare.
mayzent 0,25 mg
novartis pharma gmbh - germania - siponimod - compr. film. - 0,25mg - imunosupresoare imunosupresoare selective
mayzent 1 mg
novartis pharma gmbh - germania - siponimod - compr. film. - 1mg - imunosupresoare imunosupresoare selective
mayzent 2 mg
novartis pharma gmbh - germania - siponimod - compr. film. - 2mg - imunosupresoare imunosupresoare selective
trinomia 100 mg/20 mg/2,5 mg
ferrer internacional, s.a. - spania - acid acetylsalicylicum+atorvastatinum+ramiprilum - caps. - 100mg/20mg/2,5mg - hipolipemiante, combinatii inhibitori de hmg coa reductaza, alte combinatii
trinomia 100 mg/20 mg/5 mg
ferrer internacional, s.a. - spania - acid acetylsalicylicum+atorvastatinum+ramiprilum - caps. - 100mg/20mg/5mg - hipolipemiante, combinatii inhibitori de hmg coa reductaza, alte combinatii
trinomia 100 mg/20 mg/10 mg
ferrer internacional, s.a. - spania - acid acetylsalicylicum+atorvastatinum+ramiprilum - caps. - 100mg/20mg/10mg - hipolipemiante, combinatii inhibitori de hmg coa reductaza, alte combinatii
trinomia 100 mg/40 mg/10 mg
ferrer internacional, s.a. - spania - acid acetylsalicylicum+atorvastatinum+ramiprilum - caps. - 100mg/40mg/10mg - hipolipemiante, combinatii inhibitori de hmg coa reductaza, alte combinatii
trinomia 100 mg/40 mg/2,5 mg
ferrer internacional, s.a. - spania - acid acetylsalicylicum+atorvastatinum+ramiprilum - caps. - 100mg/40mg/2,5mg - hipolipemiante, combinatii inhibitori de hmg coa reductaza, alte combinatii
trinomia 100 mg/40 mg/5 mg
ferrer internacional, s.a. - spania - acid acetylsalicylicum+atorvastatinum+ramiprilum - caps. - 100mg/40mg/5mg - hipolipemiante, combinatii inhibitori de hmg coa reductaza, alte combinatii